Depot injection. A depot injection is an injection, usually subcutaneous, intradermal, or intramuscular, that deposits a drug in a localized mass, called a depot, from which it is gradually absorbed by surrounding tissue. Such injection allows the active compound to be released in a consistent way over a long period.
The Vanquish TM is a tunable, focused bipolar radiofrequency device which is FDA-approved for deep tissue heating. The deep tissue heating preferentially focuses in on the fat layer, and causes it to shrink by causing most of the fat cells to die off.
Twitter summary: FDA grants âtentative approvalâ to Lilly/BIâs Basaglar â new insulin option will be an alternative to Lantus in future. On August 18, Eli Lilly and Boehringer Ingelheim (BI) announced that the FDA granted âtentative approvalâ to Basaglar (insulin glargine injection) for type 1 and type 2 patients.